BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 32358)

  • 1. An in vitro method simulating drug release from viscous eye drops in rabbit and man.
    Melis-Decerf C; Ooteghem MV
    J Pharm Pharmacol; 1979 Jan; 31(1):12-5. PubMed ID: 32358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vehicle effects on ophthalmic bioavailability: the influence of different polymers on the activity of pilocarpine in rabbit and man.
    Saettone MF; Giannaccini B; Teneggi A; Savigni P; Tellini N
    J Pharm Pharmacol; 1982 Jul; 34(7):464-6. PubMed ID: 6126549
    [No Abstract]   [Full Text] [Related]  

  • 3. Flux of topical pilocarpine to the human aqueous.
    Krohn DL
    Trans Am Ophthalmol Soc; 1978; 76():502-27. PubMed ID: 754381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of biopharmaceutic characteristics of cromoglycate eye drops].
    Klimas R; Inkeniene AM; Briedis V; Gerbutaviciene RJ
    Medicina (Kaunas); 2003; 39 Suppl 2():96-103. PubMed ID: 14617868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of oily vehicle on ocular pilocarpine concentration.
    Salminen L
    Acta Ophthalmol (Copenh); 1979 Aug; 57(4):633-6. PubMed ID: 525286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation and in vitro evaluation of cysteamine hydrochloride viscous solutions for the treatment of corneal cystinosis.
    Bozdağ S; Gümüş K; Gümüş O; Unlü N
    Eur J Pharm Biopharm; 2008 Sep; 70(1):260-9. PubMed ID: 18590953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcorneal flux of topical pilocarpine to the human aqueous.
    Krohn DL; Breitfeller JM
    Am J Ophthalmol; 1979 Jan; 87(1):50-6. PubMed ID: 434053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic modeling of ophthalmic drug delivery to the anterior chamber by eye drops and contact lenses.
    Gause S; Hsu KH; Shafor C; Dixon P; Powell KC; Chauhan A
    Adv Colloid Interface Sci; 2016 Jul; 233():139-154. PubMed ID: 26318359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of methylcellulose and carboxymethylcellulose on the biological availability of eye drops containing pilocarpine hydrochloride].
    Nerlo H; Wieluńska Z
    Ann Univ Mariae Curie Sklodowska Med; 1981; 36():67-71. PubMed ID: 7052782
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of reactivity and viscosity on the action of ophthalmic drops containing cocaine and pilocarpine].
    Pankowska B; Felczak J
    Klin Oczna; 1975 Jul; 45(7):795-800. PubMed ID: 240062
    [No Abstract]   [Full Text] [Related]  

  • 11. Synergistic interaction between TS-polysaccharide and hyaluronic acid: implications in the formulation of eye drops.
    Uccello-Barretta G; Nazzi S; Zambito Y; Di Colo G; Balzano F; Sansò M
    Int J Pharm; 2010 Aug; 395(1-2):122-31. PubMed ID: 20580791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the force effect of aqueous and oily eye drops.
    Müller F; Wagner M; Neubert RH
    Pharmazie; 2005 Apr; 60(4):283-7. PubMed ID: 15881609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic and quantitative evaluation of precorneal pilocarpine disposition in albino rabbits.
    Lee VH; Robinson JR
    J Pharm Sci; 1979 Jun; 68(6):673-84. PubMed ID: 458563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative testing of eye drops with 2% pilocarpine of increased viscosity].
    Krowczyński L; Zygulska-Machowa H; Kostołowska M; Sliwińska H
    Klin Oczna; 1982 Mar; 84(3):61-2. PubMed ID: 7176455
    [No Abstract]   [Full Text] [Related]  

  • 15. On an in vitro method of simulating drug release from viscous eye drops.
    MacKeen DL
    J Pharm Pharmacol; 1979 Dec; 31(12):872. PubMed ID: 43382
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 2: Precorneal retention and in vivo pharmacodynamic study.
    Rupenthal ID; Green CR; Alany RG
    Int J Pharm; 2011 Jun; 411(1-2):78-85. PubMed ID: 21453763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antiglaucoma ophthalmic agents with prolonged action based on macromolecular excipients. 1. In vitro studies].
    Pergande G; Keipert S
    Pharmazie; 1990 Jul; 45(8):582-6. PubMed ID: 2080203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vehicle effects on ocular drug bioavailability III: Shear-facilitated pilocarpine release from ointments.
    Sieg JW; Robinson JR
    J Pharm Sci; 1979 Jun; 68(6):724-8. PubMed ID: 458573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified beta-cyclodextrin (SBE7-beta-CyD) with viscous vehicle improves the ocular delivery and tolerability of pilocarpine prodrug in rabbits.
    Jarho P; Järvinen K; Urtti A; Stella VJ; Järvinen T
    J Pharm Pharmacol; 1996 Mar; 48(3):263-9. PubMed ID: 8737051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of permeability coefficients of ophthalmic drugs through different layers of porcine, rabbit and bovine eyes.
    Loch C; Zakelj S; Kristl A; Nagel S; Guthoff R; Weitschies W; Seidlitz A
    Eur J Pharm Sci; 2012 Aug; 47(1):131-8. PubMed ID: 22659372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.